Triple Receptor Agonist
Retatrutide is an investigational triple agonist acting on GIP, GLP-1, and glucagon receptors. It represents the frontier of incretin research and is used in laboratory settings to study multi-receptor metabolic signaling.
39-residue synthetic triple agonist
Research use only. Retatrutide is supplied strictly for in-vitro laboratory and research purposes. It is not a drug or dietary supplement and is not intended for human or veterinary use, diagnosis, or consumption of any kind.